Table 2 Respiratory support for each patient at the start and end of the 72 h period of L-citrulline dosing.

From: Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia

Patient

1

2

3

4

5

6

L-citrulline dosing

Start

End

Start

End

Start

End

Start

End

Start

End

Start

End

Respiratory Support Mode

CPAP

CPAP

CPAP

CPAP

CPAP

CPAP

HFNC

HFNC

CPAP

RA

HFNC

HFNC

MAP (cm H2O) or Flow (L/min)

11

10

12

12

10

10

5

4

5

0

5

6

FiO2

24%

24%

23%

23%

29%

30%

24%

28%

21%

21%

24%

27%

  1. CPAP Continuous positive airway pressure
  2. HFNC High flow nasal cannula
  3. RA room air (i.e., no respiratory support)
  4. FiO2 fractional inspired oxygen.
Back to article page